1,3,4,6,7,8-Hexahydro-2H-pyrimido[1,2-a]pyrimidine is a bicyclic heterocyclic compound composed of a fused pyrimidine ring system. Its molecular formula is C6H12N4. The compound is a saturated bicyclic system in which one pyrimidine ring is fused to a second pyrimidine at the 1,2-positions, resulting in a hexahydro structure with hydrogenation at multiple positions of the bicyclic scaffold. It typically appears as a colorless solid with moderate solubility in polar organic solvents such as ethanol, methanol, and dimethylformamide, and low solubility in water.
The discovery and development of pyrimido[1,2-a]pyrimidine derivatives have been largely motivated by their biological and pharmacological activities. Fused bicyclic pyrimidines are known to exhibit diverse bioactivity, including antiviral, antibacterial, and enzyme inhibitory effects. The hexahydro version, being partially saturated, provides increased flexibility and altered electronic properties compared to fully aromatic analogs, which can influence receptor binding and bioavailability.
Synthesis of 1,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidine is generally carried out through condensation reactions of appropriate 1,3-diaminopyrimidine derivatives with β-dicarbonyl compounds or aldehydes. Cyclization under acidic or basic conditions allows formation of the fused bicyclic system. Reaction parameters such as solvent choice, temperature, and reaction time are optimized to favor the desired regioisomer and to avoid over-condensation or polymerization. Purification is typically performed by recrystallization or column chromatography to obtain a pure, stable compound.
Chemically, the compound exhibits the reactivity characteristic of secondary and tertiary amines within a heterocyclic scaffold. The nitrogen atoms in the fused ring system can participate in protonation, nucleophilic substitution, or coordination to metal centers, which can be exploited in organic synthesis and in medicinal chemistry. The partial saturation of the rings reduces aromaticity but increases the flexibility of the molecule, which can improve interactions with biological targets and enhance solubility.
In practical applications, hexahydro pyrimido[1,2-a]pyrimidine derivatives are explored as intermediates in the synthesis of pharmaceutical agents and biologically active compounds. The fused bicyclic structure serves as a scaffold for medicinal chemistry, allowing derivatization at multiple positions to optimize binding affinity, metabolic stability, and pharmacokinetic properties. These compounds may also be studied for their potential as enzyme inhibitors, ligands for nucleic acid binding, or central nervous system-active agents.
Physically, the compound is stable under normal laboratory conditions but should be stored in a dry, cool environment to prevent decomposition. Standard laboratory precautions, including gloves, eye protection, and ventilation, should be followed, as heterocyclic amines can be irritant or toxic upon exposure.
Overall, 1,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidine is a versatile heterocyclic scaffold with potential applications in medicinal chemistry and organic synthesis. Its fused bicyclic structure, containing multiple nitrogen atoms and partial ring saturation, provides chemical reactivity and flexibility that make it a valuable intermediate for the development of biologically active compounds and novel heterocyclic derivatives.
References
2025. Degradation technologies for condensation polymers mediated by organic catalysts. Polymer Journal.
DOI: 10.1038/s41428-025-01069-x
2025. Ring-opening Polymerization of Benzo-fused Thiolactones toward Chemically Recyclable Semi-aromatic Polythioesters. Chinese Journal of Polymer Science.
DOI: 10.1007/s10118-025-3372-0
|
![CAS # 5807-14-7, 1,3,4,6,7,8-Hexahydro-2H-pyrimido[1,2-a]pyrimidine](/structures/5807-14-7.gif)
GHS05 Danger Details
Discovery and Applications